PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE

PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE was reported 63374 times

PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 128 0.5590
1 CONGENITAL HIATUS HERNIA 107 0.4693
2 SWOLLEN JOINT COUNT 102 0.4080
3 LUPUS VULGARIS 502 0.3984
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 792 0.3954
5 C-REACTIVE PROTEIN 350 0.3776
6 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 202 0.3601
7 SWOLLEN JOINT COUNT INCREASED 924 0.2895
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 595 0.2869
9 HYPOCHOLESTEROLAEMIA 97 0.2748
10 X-RAY ABNORMAL 490 0.2737
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1859 0.2592
12 DUODENAL ULCER PERFORATION 1921 0.2581
13 DISLOCATION OF VERTEBRA 583 0.2554
14 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1653 0.2543
15 MUSCLE INJURY 2050 0.2472
16 VAGINAL FLATULENCE 74 0.2442
17 RHEUMATIC FEVER 1075 0.2409
18 FACET JOINT SYNDROME 750 0.2301
19 RETINITIS 397 0.2296
20 NEUROLOGIC NEGLECT SYNDROME 124 0.2230
21 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 146 0.2186
22 PULMONARY VASCULITIS 116 0.2156
23 RHEUMATOID FACTOR POSITIVE 1212 0.2096
24 FOLLICULITIS 2147 0.2045
25 TOTAL LUNG CAPACITY ABNORMAL 78 0.2005
26 HELICOBACTER INFECTION 1993 0.1937
27 PERIPHERAL VENOUS DISEASE 751 0.1837
28 PORPHYRIA ACUTE 255 0.1777
29 PEMPHIGUS 2156 0.1723
30 HAND DEFORMITY 2002 0.1525
31 SPIROMETRY ABNORMAL 91 0.1522
32 CAROTID ARTERY THROMBOSIS 125 0.1472
33 C-REACTIVE PROTEIN ABNORMAL 922 0.1436
34 SYNOVIAL DISORDER 63 0.1385
35 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 127 0.1370
36 ADJUSTMENT DISORDER 168 0.1292
37 MITE ALLERGY 84 0.1282
38 BONE EROSION 452 0.1277
39 PERICARDITIS 2132 0.1268
40 SYNOVITIS 2287 0.1267
41 BLOOD PRESSURE SYSTOLIC ABNORMAL 292 0.1180
42 BLOOD PRESSURE DIASTOLIC ABNORMAL 295 0.1159
43 TEMPERATURE REGULATION DISORDER 252 0.1130
44 OVERLAP SYNDROME 78 0.1114
45 SYSTEMIC INFECTION 179 0.1079
46 MYCOTIC ALLERGY 91 0.1064
47 IRRITABLE BOWEL SYNDROME 2234 0.1041
48 DUST ALLERGY 102 0.1040
49 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 70 0.0955
50 LIP DRY 866 0.0952
51 GLOSSODYNIA 2110 0.0942
52 DRUG TOLERANCE DECREASED 253 0.0900
53 BURSITIS 1083 0.0892
54 BREAST CANCER STAGE III 562 0.0867
55 AUTOIMMUNE DISORDER 833 0.0854
56 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 191 0.0828
57 HYPERCHOLESTEROLAEMIA 792 0.0819
58 WOUND INFECTION 889 0.0811
59 JOINT RANGE OF MOTION DECREASED 1088 0.0810
60 SERONEGATIVE ARTHRITIS 91 0.0794
61 WOUND 2144 0.0766
62 NEURITIS 112 0.0725
63 IMPAIRED HEALING 2315 0.0704
64 GRIP STRENGTH DECREASED 617 0.0700
65 MATERNAL EXPOSURE TIMING UNSPECIFIED 254 0.0676
66 CONTRAINDICATED PRODUCT ADMINISTERED 1967 0.0649
67 CONJUNCTIVITIS ALLERGIC 96 0.0648
68 PUSTULAR PSORIASIS 216 0.0628
69 SYSTEMIC LUPUS ERYTHEMATOSUS 2227 0.0627
70 PLEURITIC PAIN 169 0.0612
71 FIBROMYALGIA 1472 0.0605
72 TOTAL LUNG CAPACITY DECREASED 95 0.0594
73 RESPIRATORY SYMPTOM 165 0.0580
74 BLEPHAROSPASM 365 0.0579
75 JOINT DESTRUCTION 90 0.0578
76 LIVE BIRTH 479 0.0572
77 LOWER RESPIRATORY TRACT INFECTION 2603 0.0572
78 OBSTRUCTIVE SLEEP APNOEA SYNDROME 82 0.0562
79 PRODUCT MONITORING ERROR 79 0.0547
80 PULMONARY FIBROSIS 1028 0.0535
81 INFUSION SITE REACTION 159 0.0532
82 FEMALE GENITAL TRACT FISTULA 90 0.0527
83 PERSONALITY DISORDER 138 0.0526
84 OBESITY 829 0.0520
85 LIVER INJURY 1255 0.0511
86 SCIATICA 815 0.0511
87 PRESCRIBED OVERDOSE 984 0.0508
88 EXOSTOSIS 458 0.0501
89 WALKING AID USER 323 0.0489
90 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 99 0.0485
91 LOWER LIMB FRACTURE 931 0.0484
92 RED BLOOD CELL SEDIMENTATION RATE INCREASED 533 0.0481
93 FOOD ALLERGY 364 0.0471
94 CHRONIC SINUSITIS 171 0.0455
95 INFUSION SITE DISCHARGE 79 0.0450
96 ALLERGY TO CHEMICALS 56 0.0449
97 LUNG OPACITY 118 0.0447
98 RASH VESICULAR 214 0.0442
99 INFUSION RELATED REACTION 2902 0.0437
100 FULL BLOOD COUNT ABNORMAL 462 0.0436
101 BREAST CANCER STAGE II 361 0.0433
102 TYPE 2 DIABETES MELLITUS 1443 0.0428
103 ARTHROPATHY 2376 0.0427
104 FORCED EXPIRATORY VOLUME DECREASED 120 0.0423
105 STOMATITIS 2553 0.0421
106 THERAPEUTIC PRODUCT EFFECT DECREASED 1880 0.0419
107 OBSTRUCTIVE AIRWAYS DISORDER 465 0.0418
108 BLISTER 2332 0.0415
109 RHEUMATOID NODULE 113 0.0410
110 LUPUS-LIKE SYNDROME 366 0.0403
111 NIGHT SWEATS 1287 0.0399
112 HEPATIC ENZYME INCREASED 2716 0.0398
113 THERAPEUTIC REACTION TIME DECREASED 113 0.0387
114 ULCER HAEMORRHAGE 261 0.0385
115 BREATH SOUNDS ABNORMAL 189 0.0383
116 FOETAL DEATH 197 0.0380
117 SCLERITIS 60 0.0374
118 MUSCLE SPASTICITY 454 0.0369
119 PSORIATIC ARTHROPATHY 1474 0.0363
120 NORMOCHROMIC NORMOCYTIC ANAEMIA 109 0.0362
121 FOOT DEFORMITY 398 0.0359
122 EXPOSURE TO SARS-COV-2 61 0.0359
123 NASAL OBSTRUCTION 65 0.0346
124 WHEEZING 2045 0.0345
125 BENIGN PROSTATIC HYPERPLASIA 178 0.0344
126 PROCTITIS 96 0.0342
127 DISCOMFORT 2059 0.0337
128 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 567 0.0334
129 INFUSION SITE HAEMORRHAGE 109 0.0331
130 GAIT INABILITY 1082 0.0323
131 RADICULOPATHY 85 0.0322
132 BLOOD PRESSURE SYSTOLIC INCREASED 627 0.0321
133 HIP ARTHROPLASTY 490 0.0320
134 OSTEOARTHRITIS 1348 0.0318
135 C-REACTIVE PROTEIN INCREASED 1155 0.0317
136 ONYCHOMADESIS 133 0.0317
137 BRONCHIECTASIS 211 0.0313
138 SPUTUM DISCOLOURED 297 0.0313
139 PNEUMONIA VIRAL 99 0.0310
140 SINUSITIS 3182 0.0310
141 IMMUNODEFICIENCY 460 0.0308
142 ILL-DEFINED DISORDER 1874 0.0308
143 RALES 178 0.0306
144 BLOOD PRESSURE DIASTOLIC DECREASED 226 0.0306
145 SWELLING 2813 0.0300
146 JOINT DISLOCATION 314 0.0297
147 BLOOD CHOLESTEROL INCREASED 1381 0.0296
148 GASTROINTESTINAL DISORDER 2633 0.0294
149 TENOSYNOVITIS 81 0.0293
150 INFUSION SITE BRUISING 62 0.0287
151 ANTINUCLEAR ANTIBODY POSITIVE 93 0.0286
152 JOINT SWELLING 3436 0.0284
153 DRUG INTOLERANCE 2747 0.0284
154 LUNG DISORDER 1388 0.0283
155 EAR PAIN 550 0.0283
156 GANGRENE 170 0.0282
157 EYE INJURY 85 0.0280
158 COELIAC DISEASE 274 0.0279
159 RHEUMATOID ARTHRITIS 3143 0.0277
160 HEPATIC CIRRHOSIS 517 0.0275
161 SEASONAL ALLERGY 389 0.0275
162 LIVER DISORDER 1211 0.0273
163 MYOSITIS 239 0.0266
164 DEVICE INFUSION ISSUE 66 0.0266
165 TASTE DISORDER 537 0.0264
166 TACHYARRHYTHMIA 66 0.0264
167 BODY TEMPERATURE DECREASED 260 0.0264
168 VASCULAR DEVICE INFECTION 119 0.0262
169 INFUSION SITE SWELLING 164 0.0260
170 GENERAL PHYSICAL HEALTH DETERIORATION 2989 0.0258
171 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 436 0.0254
172 INFUSION SITE INFECTION 59 0.0254
173 OEDEMA 1368 0.0252
174 SPONDYLITIS 91 0.0250
175 CONTUSION 2402 0.0249
176 MUSCULOSKELETAL PAIN 1300 0.0248
177 PANNICULITIS 60 0.0248
178 INFUSION SITE ERYTHEMA 209 0.0248
179 PRESCRIBED UNDERDOSE 494 0.0247
180 NEUROLOGICAL SYMPTOM 138 0.0241
181 INFUSION SITE PRURITUS 76 0.0241
182 POOR VENOUS ACCESS 249 0.0240
183 VITAMIN B12 DECREASED 69 0.0239
184 NAIL DISORDER 209 0.0239
185 BLOOD PRESSURE DIASTOLIC INCREASED 110 0.0238
186 DELIRIUM 827 0.0238
187 KNEE ARTHROPLASTY 499 0.0237
188 DRUG TOLERANCE 119 0.0235
189 ROAD TRAFFIC ACCIDENT 984 0.0235
190 FREQUENT BOWEL MOVEMENTS 635 0.0235
191 CREPITATIONS 70 0.0235
192 INFUSION SITE PAIN 301 0.0233
193 DIVERTICULUM INTESTINAL 102 0.0233
194 DIASTOLIC DYSFUNCTION 72 0.0233
195 PERIPHERAL SWELLING 3528 0.0229
196 PULMONARY ALVEOLAR HAEMORRHAGE 126 0.0224
197 PREGNANCY 449 0.0224
198 GENERAL SYMPTOM 168 0.0224
199 ARTERIAL OCCLUSIVE DISEASE 176 0.0224
200 BLOOD PRESSURE FLUCTUATION 536 0.0223
201 THERAPY NON-RESPONDER 999 0.0222
202 ARTERIOSCLEROSIS CORONARY ARTERY 147 0.0222
203 THROAT CLEARING 83 0.0221
204 SLEEP DISORDER 1532 0.0217
205 JOINT EFFUSION 149 0.0216
206 INFECTION 3122 0.0215
207 MUSCULOSKELETAL STIFFNESS 1889 0.0215
208 FAECES SOFT 156 0.0214
209 ASTHMA 2416 0.0214
210 INTENTIONAL PRODUCT USE ISSUE 1871 0.0213
211 WEIGHT FLUCTUATION 223 0.0213
212 RESPIRATORY DISORDER 636 0.0212
213 APHTHOUS ULCER 162 0.0209
214 CUSHINGOID 67 0.0209
215 BACK INJURY 227 0.0209
216 SENSORY LOSS 168 0.0208
217 SYNOVIAL CYST 96 0.0208
218 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 105 0.0207
219 UPPER RESPIRATORY TRACT INFECTION 956 0.0207
220 BODY TEMPERATURE INCREASED 422 0.0207
221 EAR INFECTION 549 0.0206
222 SINUS CONGESTION 273 0.0202
223 INFLAMMATION 1041 0.0201
224 NASOPHARYNGITIS 3674 0.0199
225 SPINAL STENOSIS 82 0.0198
226 IRON DEFICIENCY ANAEMIA 182 0.0197
227 FAECAL CALPROTECTIN INCREASED 62 0.0196
228 MOBILITY DECREASED 1381 0.0192
229 INJURY 1338 0.0190
230 ANAL FISSURE 102 0.0190
231 MUCOUS STOOLS 94 0.0190
232 TREATMENT FAILURE 1565 0.0189
233 MATERNAL EXPOSURE DURING PREGNANCY 1652 0.0185
234 BLOOD CALCIUM INCREASED 162 0.0185
235 JOINT STIFFNESS 480 0.0183
236 RENAL CYST 144 0.0181
237 NORMAL NEWBORN 98 0.0180
238 ASPIRATION 197 0.0180
239 CONFUSIONAL STATE 2906 0.0180
240 LIVER FUNCTION TEST INCREASED 385 0.0179
241 HEMIPLEGIA 149 0.0179
242 DYSPNOEA EXERTIONAL 674 0.0179
243 HYPERVOLAEMIA 88 0.0178
244 HYPERSENSITIVITY 3305 0.0178
245 ABDOMINAL DISCOMFORT 2985 0.0178
246 SUSPECTED OFF LABEL USE 80 0.0177
247 MONOCYTE COUNT INCREASED 64 0.0176
248 VASCULITIS 205 0.0176
249 BACK DISORDER 286 0.0176
250 PEPTIC ULCER 58 0.0175
251 POLYARTHRITIS 91 0.0172
252 PARANASAL SINUS DISCOMFORT 65 0.0172
253 MACULAR DEGENERATION 205 0.0171
254 HEART RATE DECREASED 601 0.0171
255 PRODUCTIVE COUGH 812 0.0170
256 DRY MOUTH 1380 0.0170
257 TENDERNESS 177 0.0170
258 OESOPHAGEAL PAIN 67 0.0169
259 RESPIRATORY RATE INCREASED 149 0.0168
260 FLUID RETENTION 844 0.0166
261 DISABILITY 328 0.0166
262 ERYSIPELAS 83 0.0165
263 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 793 0.0165
264 ARTERIOSCLEROSIS 155 0.0165
265 NASAL POLYPS 81 0.0164
266 RESPIRATORY TRACT CONGESTION 260 0.0163
267 PRODUCT ADMINISTRATION INTERRUPTED 128 0.0163
268 GASTROOESOPHAGEAL REFLUX DISEASE 1311 0.0163
269 ORAL CANDIDIASIS 214 0.0162
270 IRON DEFICIENCY 73 0.0162
271 MOTOR DYSFUNCTION 164 0.0161
272 HYPOMAGNESAEMIA 224 0.0161
273 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 142 0.0160
274 WEIGHT INCREASED 3564 0.0159
275 NODULE 207 0.0158
276 AORTIC VALVE INCOMPETENCE 67 0.0157
277 FLANK PAIN 146 0.0156
278 OSTEOPOROSIS 638 0.0155
279 FAECES HARD 60 0.0154
280 INFUSION SITE EXTRAVASATION 95 0.0152
281 SKIN ABRASION 72 0.0152
282 OXYGEN SATURATION DECREASED 856 0.0152
283 COLITIS ULCERATIVE 678 0.0152
284 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1075 0.0151
285 ULCER 240 0.0151
286 BLOOD URIC ACID INCREASED 87 0.0151
287 OBSTRUCTION 60 0.0150
288 EPILEPSY 458 0.0150
289 ON AND OFF PHENOMENON 83 0.0149
290 ELECTROLYTE IMBALANCE 173 0.0149
291 ARTHRITIS 1169 0.0148
292 RECTAL HAEMORRHAGE 632 0.0147
293 HIATUS HERNIA 189 0.0146
294 SKIN HAEMORRHAGE 216 0.0146
295 DYSPEPSIA 1430 0.0145
296 AFFECT LABILITY 139 0.0144
297 DEFAECATION URGENCY 101 0.0144
298 ATELECTASIS 139 0.0144
299 HYPOKALAEMIA 659 0.0143
300 HAEMOPTYSIS 398 0.0143
301 HAEMOGLOBIN INCREASED 65 0.0142
302 OEDEMA PERIPHERAL 1730 0.0142
303 SINUS DISORDER 280 0.0141
304 INCORRECT DRUG ADMINISTRATION RATE 60 0.0141
305 PYREXIA 4872 0.0141
306 CYSTITIS 448 0.0141
307 HYPOCALCAEMIA 266 0.0140
308 EXPOSURE DURING PREGNANCY 861 0.0138
309 HEPATIC STEATOSIS 257 0.0138
310 FLUID INTAKE REDUCED 69 0.0138
311 HYPERTENSION 2918 0.0138
312 MICTURITION URGENCY 157 0.0137
313 BLOOD PRESSURE SYSTOLIC DECREASED 62 0.0136
314 HAEMATOCHEZIA 751 0.0136
315 DYSLIPIDAEMIA 69 0.0136
316 SPINAL OSTEOARTHRITIS 119 0.0135
317 MIGRAINE 1290 0.0135
318 UMBILICAL HERNIA 63 0.0135
319 PRE-EXISTING CONDITION IMPROVED 84 0.0134
320 BLOOD TEST ABNORMAL 189 0.0134
321 HAEMATOCRIT DECREASED 264 0.0133
322 ABNORMAL FAECES 109 0.0133
323 GASTRITIS EROSIVE 62 0.0133
324 TOXIC EPIDERMAL NECROLYSIS 200 0.0132
325 GASTRIC ULCER 250 0.0131
326 ABDOMINAL PAIN UPPER 2699 0.0131
327 ANGINA PECTORIS 375 0.0131
328 RED BLOOD CELL COUNT DECREASED 374 0.0131
329 CACHEXIA 67 0.0130
330 RESPIRATORY TRACT INFECTION 339 0.0130
331 ALOPECIA 2552 0.0130
332 BLOOD MAGNESIUM DECREASED 112 0.0130
333 FAECALOMA 71 0.0129
334 MULTIPLE ALLERGIES 100 0.0127
335 SECRETION DISCHARGE 158 0.0126
336 ANAL INCONTINENCE 112 0.0124
337 UPPER-AIRWAY COUGH SYNDROME 102 0.0124
338 PULMONARY MASS 184 0.0123
339 HEMIPARESIS 209 0.0123
340 SKIN NECROSIS 64 0.0123
341 COORDINATION ABNORMAL 171 0.0122
342 HYPOAESTHESIA 1830 0.0122
343 POLYNEUROPATHY 146 0.0122
344 LYMPHOEDEMA 84 0.0121
345 POSTOPERATIVE WOUND INFECTION 82 0.0121
346 WHITE BLOOD CELL COUNT INCREASED 465 0.0121
347 TROPONIN INCREASED 92 0.0121
348 URTICARIA 2023 0.0121
349 DRUG-INDUCED LIVER INJURY 378 0.0120
350 MEDICATION ERROR 668 0.0120
351 SLEEP APNOEA SYNDROME 229 0.0120
352 SENSITIVITY TO WEATHER CHANGE 63 0.0120
353 ARTHRALGIA 4977 0.0120
354 HYPONATRAEMIA 674 0.0120
355 HYPERTRANSAMINASAEMIA 83 0.0119
356 INFLAMMATORY MARKER INCREASED 59 0.0119
357 HAEMORRHOIDS 232 0.0119
358 HAEMORRHOIDAL HAEMORRHAGE 58 0.0119
359 AMNESIA 771 0.0118
360 CHEST PAIN 2182 0.0118
361 CONDITION AGGRAVATED 3569 0.0117
362 ABDOMINAL PAIN 2722 0.0117
363 EATING DISORDER 248 0.0116
364 MELAENA 256 0.0116
365 PNEUMONIA 3765 0.0116
366 BLOOD IRON DECREASED 137 0.0115
367 GASTRITIS 299 0.0114
368 BRONCHITIS 839 0.0113
369 SKIN LACERATION 123 0.0113
370 BLOOD PRESSURE INCREASED 1725 0.0113
371 RHINORRHOEA 729 0.0113
372 UROSEPSIS 103 0.0112
373 DECREASED APPETITE 2583 0.0111
374 CONGENITAL ANOMALY 86 0.0111
375 GAMMA-GLUTAMYLTRANSFERASE INCREASED 246 0.0111
376 HYPERCALCAEMIA 137 0.0111
377 POLYURIA 90 0.0110
378 OESOPHAGITIS 120 0.0110
379 OVERWEIGHT 59 0.0110
380 LARGE INTESTINE POLYP 76 0.0110
381 BLOOD ALBUMIN DECREASED 87 0.0110
382 EXERCISE TOLERANCE DECREASED 63 0.0109
383 CLOSTRIDIUM DIFFICILE COLITIS 116 0.0109
384 HYPOXIA 385 0.0109
385 DYSPNOEA 6186 0.0109
386 RHINITIS 88 0.0109
387 JOINT INJURY 233 0.0109
388 SNEEZING 244 0.0109
389 MUSCULAR WEAKNESS 1236 0.0109
390 PROTHROMBIN TIME PROLONGED 65 0.0109
391 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 565 0.0108
392 TRICUSPID VALVE INCOMPETENCE 86 0.0108
393 PRODUCT USE ISSUE 2034 0.0108
394 LEUKOPENIA 537 0.0107
395 LIGAMENT SPRAIN 106 0.0107
396 WEIGHT DECREASED 2980 0.0107
397 CONJUNCTIVITIS 198 0.0107
398 TRANSAMINASES INCREASED 237 0.0106
399 ADRENAL INSUFFICIENCY 129 0.0106
400 MITRAL VALVE INCOMPETENCE 120 0.0106
401 HYPOPHOSPHATAEMIA 78 0.0105
402 HYPERTENSIVE CRISIS 117 0.0105
403 DRUG LEVEL BELOW THERAPEUTIC 58 0.0105
404 ANAL FISTULA 56 0.0105
405 GOUT 188 0.0105
406 POST PROCEDURAL INFECTION 85 0.0104
407 RESPIRATORY SYNCYTIAL VIRUS INFECTION 91 0.0104
408 STREPTOCOCCAL INFECTION 58 0.0104
409 VITAMIN D DECREASED 89 0.0104
410 ANKYLOSING SPONDYLITIS 137 0.0104
411 HEPATITIS 265 0.0103
412 DERMATITIS ALLERGIC 130 0.0103
413 ANAEMIA 1970 0.0103
414 PRODUCT PRESCRIBING ERROR 245 0.0103
415 NASAL DRYNESS 64 0.0102
416 LIMB INJURY 277 0.0102
417 GASTROENTERITIS 148 0.0101
418 HYPERLIPIDAEMIA 121 0.0101
419 RASH 4405 0.0101
420 DERMATITIS CONTACT 115 0.0101
421 PRURITUS 3862 0.0100
422 LIPASE INCREASED 77 0.0100
423 LABORATORY TEST ABNORMAL 295 0.0100
424 ASTHENIA 3754 0.0100
425 ATRIOVENTRICULAR BLOCK 77 0.0100
426 PAIN 6112 0.0099
427 TACHYPNOEA 135 0.0099
428 POLYP 65 0.0099
429 PARAESTHESIA ORAL 143 0.0099
430 HYPOTHYROIDISM 316 0.0099
431 THROMBOCYTOPENIA 1104 0.0099
432 COVID-19 PNEUMONIA 116 0.0098
433 TOOTH ABSCESS 100 0.0098
434 ELECTROCARDIOGRAM ABNORMAL 77 0.0098
435 MIDDLE INSOMNIA 183 0.0098
436 MYASTHENIA GRAVIS 79 0.0098
437 RASH ERYTHEMATOUS 467 0.0098
438 GASTROENTERITIS VIRAL 176 0.0097
439 LOWER GASTROINTESTINAL HAEMORRHAGE 72 0.0097
440 TOOTH INFECTION 128 0.0097
441 FISTULA 109 0.0097
442 ENTERITIS 62 0.0097
443 FATIGUE 7509 0.0096
444 DIARRHOEA HAEMORRHAGIC 90 0.0096
445 HAEMOGLOBIN DECREASED 985 0.0096
446 EYE PAIN 540 0.0096
447 EYE INFLAMMATION 91 0.0095
448 FEELING HOT 584 0.0095
449 UPPER GASTROINTESTINAL HAEMORRHAGE 160 0.0095
450 GASTROINTESTINAL INFECTION 85 0.0095
451 OROPHARYNGEAL PAIN 877 0.0095
452 COUGH 2654 0.0095
453 PANCREATITIS 500 0.0095
454 THERMAL BURN 67 0.0094
455 RASH MACULO-PAPULAR 210 0.0094
456 CHEST DISCOMFORT 965 0.0094
457 INTERVERTEBRAL DISC DEGENERATION 87 0.0094
458 VAGINAL DISCHARGE 95 0.0094
459 HYDRONEPHROSIS 70 0.0093
460 CLOSTRIDIUM DIFFICILE INFECTION 204 0.0093
461 SKIN ULCER 241 0.0093
462 CORONARY ARTERY DISEASE 282 0.0093
463 CANDIDA INFECTION 156 0.0092
464 DRUG LEVEL DECREASED 94 0.0092
465 HAEMATEMESIS 234 0.0092
466 NOCTURIA 112 0.0092
467 BACTERIAL INFECTION 172 0.0092
468 DIVERTICULITIS 255 0.0092
469 MEMORY IMPAIRMENT 1264 0.0092
470 PURPURA 81 0.0091
471 HYPERKALAEMIA 321 0.0091
472 RESPIRATION ABNORMAL 63 0.0091
473 PLEURAL EFFUSION 554 0.0091
474 DRUG ERUPTION 161 0.0091
475 PARAESTHESIA 1425 0.0090
476 INFLUENZA 1010 0.0090
477 PRESYNCOPE 220 0.0090
478 LYMPHOCYTE COUNT DECREASED 159 0.0090
479 BLOOD SODIUM DECREASED 169 0.0090
480 ORAL PAIN 200 0.0089
481 DIARRHOEA 5757 0.0089
482 DRUG SPECIFIC ANTIBODY PRESENT 58 0.0089
483 ARTHROPOD BITE 66 0.0089
484 VOMITING 4179 0.0089
485 RASH PRURITIC 479 0.0088
486 ATRIAL FIBRILLATION 859 0.0088
487 ORAL HERPES 172 0.0088
488 BASAL CELL CARCINOMA 137 0.0088
489 BLOOD LACTATE DEHYDROGENASE INCREASED 139 0.0088
490 CONSTIPATION 1908 0.0087
491 MUSCLE SPASMS 1605 0.0087
492 DYSPHONIA 511 0.0087
493 HAEMATURIA 299 0.0087
494 MUSCULOSKELETAL CHEST PAIN 135 0.0087
495 BLOOD CALCIUM DECREASED 98 0.0087
496 NASAL CONGESTION 512 0.0087
497 CARDIOMEGALY 107 0.0087
498 INSURANCE ISSUE 133 0.0087
499 ILEUS 108 0.0087
500 BACK PAIN 2017 0.0087
501 CATARACT 517 0.0087
502 EOSINOPHILIA 151 0.0086
503 LIMB DISCOMFORT 266 0.0086
504 NEURALGIA 209 0.0086
505 BLOOD CREATININE INCREASED 561 0.0086
506 DECUBITUS ULCER 70 0.0086
507 PHOTOPHOBIA 161 0.0086
508 DECREASED IMMUNE RESPONSIVENESS 84 0.0086
509 DIZZINESS POSTURAL 83 0.0086
510 GLOMERULAR FILTRATION RATE DECREASED 105 0.0085
511 CHOLESTASIS 164 0.0085
512 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 66 0.0085
513 BLOOD POTASSIUM DECREASED 255 0.0085
514 SARS-COV-2 TEST POSITIVE 112 0.0085
515 HEADACHE 5314 0.0085
516 COLITIS 321 0.0085
517 SMALL INTESTINAL OBSTRUCTION 104 0.0084
518 APHASIA 255 0.0084
519 END STAGE RENAL DISEASE 154 0.0084
520 CYTOKINE RELEASE SYNDROME 169 0.0084
521 KIDNEY INFECTION 165 0.0084
522 PAIN IN EXTREMITY 2477 0.0084
523 PSEUDOMONAS INFECTION 72 0.0084
524 SWOLLEN TONGUE 262 0.0084
525 TUBULOINTERSTITIAL NEPHRITIS 157 0.0084
526 URINARY TRACT INFECTION 1426 0.0084
527 COVID-19 1459 0.0083
528 DIVERTICULUM 59 0.0083
529 PRODUCT DISTRIBUTION ISSUE 77 0.0083
530 NEPHROLITHIASIS 380 0.0083
531 ILLNESS 850 0.0082
532 PANCYTOPENIA 461 0.0082
533 FEBRILE NEUTROPENIA 547 0.0082
534 HEART RATE IRREGULAR 185 0.0082
535 INSOMNIA 2180 0.0082
536 GASTROINTESTINAL INFLAMMATION 64 0.0082
537 CONCUSSION 63 0.0081
538 SPINAL PAIN 95 0.0081
539 MYOPATHY 70 0.0081
540 INTERVERTEBRAL DISC PROTRUSION 177 0.0081
541 GASTROINTESTINAL PAIN 89 0.0081
542 GROIN PAIN 71 0.0081
543 CARDIAC FAILURE 649 0.0081
544 DUODENAL ULCER 57 0.0081
545 RIB FRACTURE 166 0.0081
546 RENAL TUBULAR NECROSIS 79 0.0080
547 VIRAL INFECTION 267 0.0080
548 THROAT IRRITATION 360 0.0080
549 NECK PAIN 448 0.0080
550 DYSURIA 295 0.0080
551 GENERALISED OEDEMA 99 0.0080
552 HEART RATE INCREASED 792 0.0080
553 CIRCULATORY COLLAPSE 136 0.0080
554 SHOCK HAEMORRHAGIC 65 0.0080
555 FAECES DISCOLOURED 173 0.0080
556 CYST 99 0.0080
557 GAIT DISTURBANCE 1526 0.0080
558 PYELONEPHRITIS 69 0.0080
559 NERVE COMPRESSION 73 0.0079
560 SEPTIC SHOCK 343 0.0079
561 INTESTINAL OBSTRUCTION 297 0.0079
562 AGRANULOCYTOSIS 146 0.0078
563 ABSCESS 125 0.0078
564 NEPHROPATHY 73 0.0078
565 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1409 0.0078
566 PSORIASIS 1020 0.0078
567 HAEMATOMA 202 0.0078
568 ESCHERICHIA INFECTION 64 0.0078
569 SOPOR 103 0.0078
570 SCRATCH 82 0.0078
571 PHARYNGITIS STREPTOCOCCAL 84 0.0078
572 DEHYDRATION 1035 0.0078
573 MALAISE 3402 0.0077
574 SKIN INFECTION 87 0.0077
575 FULL BLOOD COUNT DECREASED 156 0.0077
576 CHOLECYSTITIS 92 0.0077
577 ASCITES 227 0.0077
578 PROCEDURAL PAIN 214 0.0077
579 HERPES ZOSTER 443 0.0077
580 ADVERSE EVENT 710 0.0077
581 HOSPICE CARE 76 0.0077
582 VITAMIN D DEFICIENCY 75 0.0077
583 EOSINOPHIL COUNT INCREASED 64 0.0077
584 PETECHIAE 80 0.0077
585 MOUTH ULCERATION 161 0.0076
586 BLOOD POTASSIUM INCREASED 124 0.0076
587 THROMBOSIS 614 0.0076
588 PALLOR 207 0.0076
589 RETCHING 162 0.0076
590 CHOLELITHIASIS 249 0.0076
591 BOWEL MOVEMENT IRREGULARITY 58 0.0076
592 HYPOTENSION 1516 0.0075
593 ABDOMINAL PAIN LOWER 191 0.0075
594 EMPHYSEMA 76 0.0075
595 LOCALISED INFECTION 182 0.0075
596 SKIN REACTION 106 0.0075
597 UVEITIS 102 0.0075
598 FALL 2502 0.0075
599 ACUTE KIDNEY INJURY 1143 0.0075
600 RENAL PAIN 79 0.0074
601 EPISTAXIS 555 0.0074
602 DYSARTHRIA 279 0.0074
603 OCULAR DISCOMFORT 83 0.0074
604 OFF LABEL USE 6452 0.0074
605 ABDOMINAL DISTENSION 768 0.0073
606 WRIST FRACTURE 88 0.0073
607 SWELLING FACE 478 0.0073
608 RENAL FAILURE ACUTE 311 0.0073
609 HEPATOMEGALY 72 0.0073
610 PELVIC FRACTURE 57 0.0073
611 POOR QUALITY SLEEP 157 0.0073
612 PLATELET COUNT INCREASED 95 0.0073
613 ALANINE AMINOTRANSFERASE INCREASED 447 0.0073
614 PULMONARY HYPERTENSION 151 0.0072
615 FLATULENCE 410 0.0072
616 GALLBLADDER DISORDER 129 0.0072
617 NAUSEA 5700 0.0072
618 RENAL IMPAIRMENT 605 0.0072
619 IMPAIRED GASTRIC EMPTYING 98 0.0072
620 PERICARDIAL EFFUSION 166 0.0072
621 HEREDITARY ANGIOEDEMA 77 0.0072
622 EYE INFECTION 81 0.0072
623 ACUTE RESPIRATORY FAILURE 138 0.0072
624 HYPOPHAGIA 183 0.0072
625 INTENTIONAL DOSE OMISSION 203 0.0071
626 TRANSIENT ISCHAEMIC ATTACK 240 0.0071
627 DIZZINESS 3546 0.0071
628 HERNIA 137 0.0071
629 PNEUMONIA BACTERIAL 65 0.0071
630 TOOTH DISORDER 157 0.0071
631 ANXIETY 1997 0.0070
632 DYSPHAGIA 666 0.0070
633 PULMONARY CONGESTION 92 0.0070
634 ADVERSE DRUG REACTION 625 0.0070
635 BLOOD PRESSURE ABNORMAL 138 0.0069
636 NEUTROPHIL COUNT INCREASED 71 0.0069
637 TACHYCARDIA 615 0.0069
638 EAR DISCOMFORT 71 0.0069
639 SPLENOMEGALY 81 0.0069
640 FUNGAL INFECTION 230 0.0069
641 TRANSFUSION 72 0.0069
642 DEFORMITY 64 0.0068
643 HYPERHIDROSIS 882 0.0068
644 ASPARTATE AMINOTRANSFERASE INCREASED 363 0.0068
645 BLOOD PRESSURE DECREASED 454 0.0068
646 MUCOSAL INFLAMMATION 178 0.0068
647 PULMONARY EMBOLISM 646 0.0068
648 HEAD DISCOMFORT 120 0.0068
649 CELLULITIS 341 0.0068
650 SEPSIS 753 0.0067
651 BLOOD UREA INCREASED 113 0.0067
652 PHARYNGEAL SWELLING 66 0.0067
653 SYNCOPE 674 0.0067
654 THERAPEUTIC RESPONSE SHORTENED 223 0.0067
655 FACIAL PAIN 60 0.0067
656 PRODUCT USE IN UNAPPROVED INDICATION 1664 0.0067
657 ANGIOEDEMA 297 0.0067
658 CARPAL TUNNEL SYNDROME 94 0.0067
659 LUNG INFILTRATION 59 0.0067
660 NEUTROPHIL COUNT DECREASED 268 0.0066
661 FEEDING DISORDER 133 0.0066
662 MASS 91 0.0065
663 HYPOTONIA 65 0.0065
664 URINARY INCONTINENCE 192 0.0065
665 PNEUMOCYSTIS JIROVECII PNEUMONIA 65 0.0065
666 URINARY RETENTION 216 0.0065
667 DEPRESSION 1470 0.0065
668 WHITE BLOOD CELL COUNT DECREASED 700 0.0065
669 VISUAL IMPAIRMENT 800 0.0064
670 TOXIC SKIN ERUPTION 65 0.0064
671 APHONIA 90 0.0064
672 DEVICE RELATED INFECTION 99 0.0064
673 PULMONARY OEDEMA 287 0.0064
674 POST PROCEDURAL COMPLICATION 123 0.0064
675 BLOOD BILIRUBIN INCREASED 173 0.0064
676 LIVER FUNCTION TEST ABNORMAL 186 0.0064
677 SPINAL FRACTURE 128 0.0064
678 BRAIN FOG 100 0.0064
679 SUPRAVENTRICULAR TACHYCARDIA 61 0.0064
680 BLOOD ALKALINE PHOSPHATASE INCREASED 158 0.0064
681 DIALYSIS 90 0.0063
682 QUALITY OF LIFE DECREASED 85 0.0063
683 CHRONIC KIDNEY DISEASE 481 0.0063
684 DRUG INTERACTION 1002 0.0063
685 OROPHARYNGEAL DISCOMFORT 57 0.0063
686 INTENTIONAL PRODUCT MISUSE 549 0.0063
687 RESTLESS LEGS SYNDROME 114 0.0063
688 VENTRICULAR EXTRASYSTOLES 65 0.0063
689 FEELING COLD 174 0.0062
690 BLADDER DISORDER 62 0.0062
691 ACUTE MYOCARDIAL INFARCTION 184 0.0062
692 BRADYCARDIA 329 0.0062
693 ERUCTATION 120 0.0062
694 PULMONARY THROMBOSIS 67 0.0061
695 PNEUMONITIS 167 0.0061
696 MULTI-ORGAN FAILURE 106 0.0061
697 SINUS TACHYCARDIA 87 0.0061
698 PLATELET COUNT DECREASED 652 0.0061
699 PNEUMOTHORAX 97 0.0061
700 MULTIPLE ORGAN DYSFUNCTION SYNDROME 173 0.0061
701 PAIN IN JAW 173 0.0061
702 HEAD INJURY 193 0.0061
703 INFLUENZA LIKE ILLNESS 501 0.0061
704 LYMPHOPENIA 86 0.0061
705 ANKLE FRACTURE 94 0.0061
706 HYPERGLYCAEMIA 221 0.0061
707 CARDIOGENIC SHOCK 87 0.0061
708 HEPATOTOXICITY 135 0.0061
709 SKIN LESION 166 0.0060
710 INTERNAL HAEMORRHAGE 69 0.0060
711 RESTLESSNESS 220 0.0060
712 PHOTOSENSITIVITY REACTION 99 0.0060
713 SKIN FISSURES 117 0.0060
714 PALPITATIONS 698 0.0060
715 BLOOD URINE PRESENT 113 0.0059
716 JAUNDICE 159 0.0059
717 ARRHYTHMIA 279 0.0059
718 GASTROINTESTINAL HAEMORRHAGE 491 0.0059
719 BREAST CANCER METASTATIC 63 0.0059
720 OSTEOPENIA 89 0.0059
721 EJECTION FRACTION DECREASED 91 0.0058
722 HYPOKINESIA 85 0.0058
723 FEMUR FRACTURE 181 0.0058
724 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 60 0.0058
725 HEPATIC FAILURE 174 0.0058
726 INCONTINENCE 61 0.0058
727 MOVEMENT DISORDER 185 0.0058
728 ERYTHEMA 1184 0.0058
729 HYPERSOMNIA 165 0.0057
730 DISORIENTATION 228 0.0057
731 TENDONITIS 89 0.0057
732 THERAPEUTIC RESPONSE DECREASED 348 0.0057
733 PRODUCT ADMINISTRATION ERROR 116 0.0057
734 FEELING JITTERY 109 0.0057
735 CARDIOVASCULAR DISORDER 145 0.0057
736 OVARIAN CYST 57 0.0057
737 PANCREATITIS ACUTE 128 0.0057
738 MUSCULOSKELETAL DISCOMFORT 98 0.0057
739 METASTASES TO LIVER 100 0.0057
740 CHILLS 665 0.0057
741 METASTASES TO CENTRAL NERVOUS SYSTEM 73 0.0057
742 SUBDURAL HAEMATOMA 81 0.0057
743 DECREASED ACTIVITY 61 0.0056
744 DRY EYE 282 0.0056
745 PHARYNGITIS 70 0.0056
746 RHABDOMYOLYSIS 235 0.0056
747 ECZEMA 294 0.0056
748 FOOT FRACTURE 106 0.0056
749 VENTRICULAR TACHYCARDIA 92 0.0056
750 METABOLIC ACIDOSIS 178 0.0056
751 RENAL FAILURE 739 0.0056
752 INITIAL INSOMNIA 57 0.0055
753 DEVICE OCCLUSION 78 0.0055
754 STEVENS-JOHNSON SYNDROME 123 0.0055
755 INTERNATIONAL NORMALISED RATIO INCREASED 157 0.0055
756 HYPOAESTHESIA ORAL 83 0.0055
757 HYPERBILIRUBINAEMIA 57 0.0055
758 PRODUCT DOSE OMISSION ISSUE 1612 0.0055
759 NEOPLASM 63 0.0055
760 PROTEINURIA 104 0.0055
761 BRONCHOSPASM 78 0.0055
762 TOOTH EXTRACTION 68 0.0055
763 HYPERTHYROIDISM 79 0.0055
764 FACE OEDEMA 92 0.0054
765 NEUTROPENIA 739 0.0054
766 UPPER LIMB FRACTURE 108 0.0054
767 HYPOGLYCAEMIA 262 0.0054
768 BACTERAEMIA 64 0.0054
769 GASTRIC HAEMORRHAGE 62 0.0054
770 VERTIGO 328 0.0054
771 MYALGIA 914 0.0054
772 PRODUCT DOSE OMISSION IN ERROR 152 0.0054
773 DIABETES MELLITUS 408 0.0053
774 HALLUCINATION, VISUAL 113 0.0053
775 BLOOD CREATINE PHOSPHOKINASE INCREASED 154 0.0053
776 PULMONARY ARTERIAL HYPERTENSION 77 0.0053
777 BONE PAIN 311 0.0053
778 DEMENTIA 148 0.0053
779 ROTATOR CUFF SYNDROME 68 0.0053
780 NEUROPATHY PERIPHERAL 499 0.0052
781 LOSS OF CONSCIOUSNESS 671 0.0052
782 LACRIMATION INCREASED 158 0.0052
783 POLLAKIURIA 218 0.0052
784 COGNITIVE DISORDER 243 0.0052
785 SCAR 89 0.0052
786 SPINAL OPERATION 64 0.0052
787 RENAL DISORDER 242 0.0052
788 LEUKOCYTOSIS 93 0.0051
789 HIP FRACTURE 164 0.0051
790 MALNUTRITION 57 0.0051
791 HOT FLUSH 383 0.0051
792 INTERSTITIAL LUNG DISEASE 246 0.0051
793 CHOKING 99 0.0051
794 MULTIPLE FRACTURES 83 0.0050
795 TINNITUS 231 0.0050
796 CYANOSIS 79 0.0050
797 MUSCLE RIGIDITY 60 0.0050
798 CEREBRAL HAEMORRHAGE 179 0.0050
799 SKIN EXFOLIATION 420 0.0050
800 RESPIRATORY FAILURE 363 0.0050
801 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 128 0.0050
802 PERIPHERAL COLDNESS 68 0.0049
803 INJECTION SITE EXTRAVASATION 61 0.0049
804 SPEECH DISORDER 259 0.0049
805 DYSSTASIA 144 0.0049
806 THYROID DISORDER 76 0.0049
807 GASTRIC DISORDER 169 0.0049
808 BURNING SENSATION 343 0.0049
809 AGEUSIA 122 0.0049
810 STAPHYLOCOCCAL INFECTION 161 0.0049
811 ACUTE MYELOID LEUKAEMIA 76 0.0049
812 UNDERDOSE 355 0.0049
813 ELECTROCARDIOGRAM QT PROLONGED 174 0.0048
814 TREMOR 802 0.0048
815 CHROMATURIA 109 0.0048
816 THERAPY PARTIAL RESPONDER 75 0.0048
817 SENSORY DISTURBANCE 77 0.0048
818 COLD SWEAT 84 0.0048
819 INCREASED APPETITE 91 0.0048
820 TOOTHACHE 86 0.0047
821 HOSPITALISATION 727 0.0047
822 ENCEPHALOPATHY 116 0.0047
823 ORTHOSTATIC HYPOTENSION 82 0.0047
824 MYELODYSPLASTIC SYNDROME 68 0.0047
825 METASTASES TO BONE 77 0.0047
826 BLOOD COUNT ABNORMAL 71 0.0047
827 PLASMA CELL MYELOMA 182 0.0047
828 DRUG EFFECT LESS THAN EXPECTED 69 0.0047
829 EYE IRRITATION 266 0.0046
830 PRODUCT USE COMPLAINT 72 0.0046
831 EYE SWELLING 170 0.0046
832 PNEUMONIA ASPIRATION 114 0.0046
833 SKIN CANCER 98 0.0045
834 OCULAR HYPERAEMIA 216 0.0045
835 CARDIAC DISORDER 425 0.0045
836 SKIN DISORDER 151 0.0045
837 HEPATOCELLULAR INJURY 64 0.0045
838 BALANCE DISORDER 390 0.0045
839 MUSCLE TIGHTNESS 73 0.0045
840 LYMPHADENOPATHY 159 0.0045
841 MALIGNANT MELANOMA 60 0.0045
842 DRUG INEFFECTIVE 5859 0.0044
843 PERITONITIS 92 0.0044
844 DEAFNESS 116 0.0044
845 BONE MARROW FAILURE 90 0.0044
846 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 243 0.0044
847 ORAL DISCOMFORT 61 0.0044
848 IMPAIRED QUALITY OF LIFE 63 0.0044
849 DEPRESSED MOOD 230 0.0043
850 LYMPHOMA 67 0.0043
851 DEEP VEIN THROMBOSIS 280 0.0043
852 CORONARY ARTERY OCCLUSION 58 0.0042
853 CARDIOMYOPATHY 62 0.0042
854 DRUG TOXICITY 57 0.0042
855 DIABETES MELLITUS INADEQUATE CONTROL 74 0.0042
856 DRUG LEVEL INCREASED 69 0.0042
857 NEOPLASM PROGRESSION 144 0.0041
858 BLOOD TRIGLYCERIDES INCREASED 73 0.0041
859 SOMNOLENCE 831 0.0041
860 LUNG INFECTION 64 0.0041
861 OSTEOMYELITIS 74 0.0041
862 BONE DISORDER 74 0.0041
863 RASH MACULAR 140 0.0040
864 DIPLOPIA 103 0.0040
865 THROAT TIGHTNESS 107 0.0040
866 CARDIAC FAILURE CONGESTIVE 316 0.0039
867 THIRST 69 0.0039
868 HALLUCINATION 288 0.0038
869 DERMATITIS 80 0.0038
870 DISTURBANCE IN ATTENTION 205 0.0038
871 LETHARGY 218 0.0038
872 SKIN DISCOLOURATION 174 0.0038
873 VISION BLURRED 517 0.0038
874 GLYCOSYLATED HAEMOGLOBIN INCREASED 95 0.0038
875 FLUSHING 382 0.0038
876 DEPRESSED LEVEL OF CONSCIOUSNESS 148 0.0037
877 HYPOACUSIS 161 0.0037
878 TREATMENT NONCOMPLIANCE 204 0.0037
879 CEREBROVASCULAR ACCIDENT 629 0.0037
880 FEELING ABNORMAL 888 0.0037
881 ANAPHYLACTIC REACTION 203 0.0037
882 SHOCK 84 0.0036
883 IMPAIRED WORK ABILITY 78 0.0036
884 RESPIRATORY DISTRESS 100 0.0036
885 LACTIC ACIDOSIS 117 0.0036
886 ANAPHYLACTIC SHOCK 93 0.0036
887 UNRESPONSIVE TO STIMULI 93 0.0036
888 BLOOD GLUCOSE ABNORMAL 66 0.0036
889 PRODUCT AVAILABILITY ISSUE 81 0.0036
890 SURGERY 208 0.0035
891 EYE PRURITUS 119 0.0035
892 DISEASE PROGRESSION 416 0.0035
893 THERAPY INTERRUPTED 251 0.0035
894 MALIGNANT NEOPLASM PROGRESSION 359 0.0035
895 ACUTE RESPIRATORY DISTRESS SYNDROME 62 0.0035
896 MYOCARDIAL INFARCTION 603 0.0035
897 BONE DENSITY DECREASED 107 0.0034
898 MUSCULOSKELETAL DISORDER 65 0.0034
899 FRACTURE 64 0.0034
900 MOOD ALTERED 92 0.0034
901 MENTAL STATUS CHANGES 93 0.0033
902 CARDIAC ARREST 276 0.0033
903 COMA 159 0.0033
904 NEOPLASM MALIGNANT 222 0.0033
905 DYSKINESIA 135 0.0033
906 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 77 0.0033
907 DYSGEUSIA 245 0.0033
908 NEEDLE ISSUE 96 0.0033
909 PANIC ATTACK 120 0.0033
910 EYE DISORDER 106 0.0032
911 DRY SKIN 430 0.0032
912 SEIZURE 369 0.0032
913 ALTERED STATE OF CONSCIOUSNESS 69 0.0032
914 SEROTONIN SYNDROME 61 0.0032
915 RASH PAPULAR 71 0.0032
916 SUICIDE ATTEMPT 191 0.0031
917 MUSCLE TWITCHING 72 0.0031
918 HAEMORRHAGE 325 0.0031
919 GLAUCOMA 59 0.0031
920 PAIN OF SKIN 82 0.0030
921 RENAL INJURY 90 0.0030
922 PRURITUS GENERALISED 65 0.0030
923 OVERDOSE 645 0.0030
924 NERVOUSNESS 155 0.0030
925 DISEASE RECURRENCE 141 0.0030
926 UNEVALUABLE EVENT 224 0.0030
927 AGITATION 215 0.0029
928 OSTEONECROSIS OF JAW 72 0.0029
929 CEREBRAL INFARCTION 71 0.0029
930 MENTAL DISORDER 126 0.0029
931 ACCIDENTAL OVERDOSE 103 0.0028
932 PRODUCT QUALITY ISSUE 380 0.0028
933 NERVOUS SYSTEM DISORDER 85 0.0027
934 MENTAL IMPAIRMENT 66 0.0027
935 SUICIDAL IDEATION 246 0.0027
936 HEPATIC FUNCTION ABNORMAL 99 0.0026
937 CRYING 96 0.0026
938 DEVICE DISLOCATION 112 0.0026
939 DEATH 2187 0.0025
940 LUNG NEOPLASM MALIGNANT 104 0.0025
941 FEAR 68 0.0025
942 INCORRECT DOSE ADMINISTERED 577 0.0025
943 INJECTION SITE BRUISING 201 0.0025
944 INJECTION SITE SWELLING 192 0.0025
945 NIGHTMARE 86 0.0025
946 PRODUCT DOSE OMISSION 162 0.0025
947 PRODUCT SUBSTITUTION ISSUE 142 0.0025
948 AGGRESSION 122 0.0024
949 LIP SWELLING 81 0.0024
950 MULTIPLE SCLEROSIS 116 0.0024
951 OSTEONECROSIS 79 0.0024
952 SEDATION 62 0.0024
953 RASH GENERALISED 61 0.0024
954 BLOOD GLUCOSE INCREASED 432 0.0023
955 INJECTION SITE RASH 70 0.0023
956 CARDIO-RESPIRATORY ARREST 95 0.0023
957 DEVICE ISSUE 201 0.0022
958 BLINDNESS 91 0.0022
959 INJECTION SITE PAIN 681 0.0022
960 ACNE 166 0.0022
961 ANHEDONIA 57 0.0022
962 BLOOD GLUCOSE DECREASED 103 0.0021
963 THERAPEUTIC RESPONSE UNEXPECTED 96 0.0021
964 INJECTION SITE ERYTHEMA 261 0.0021
965 FOETAL EXPOSURE DURING PREGNANCY 170 0.0021
966 THERAPY CESSATION 107 0.0021
967 INJECTION SITE PRURITUS 139 0.0021
968 CONVULSION 111 0.0019
969 MULTIPLE SCLEROSIS RELAPSE 132 0.0019
970 DERMATITIS ATOPIC 100 0.0019
971 INJECTION SITE MASS 69 0.0019
972 VISUAL ACUITY REDUCED 61 0.0018
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 357 0.0018
974 IRRITABILITY 99 0.0016
975 INJECTION SITE REACTION 110 0.0016
976 DEVICE LEAKAGE 69 0.0016
977 INJECTION SITE HAEMORRHAGE 122 0.0015
978 ABNORMAL BEHAVIOUR 59 0.0015
979 DRUG ABUSE 120 0.0014
980 SKIN IRRITATION 65 0.0014
981 WITHDRAWAL SYNDROME 59 0.0014
982 DEVICE MALFUNCTION 85 0.0012
983 INTENTIONAL OVERDOSE 76 0.0012
984 BREAST CANCER 105 0.0011
985 EMOTIONAL DISTRESS 135 0.0011
986 TOXICITY TO VARIOUS AGENTS 183 0.0011
987 NO ADVERSE EVENT 196 0.0011
988 SKIN BURNING SENSATION 74 0.0010
989 PROSTATE CANCER 75 0.0009
990 DRUG DOSE OMISSION 149 0.0009
991 ACCIDENTAL EXPOSURE TO PRODUCT 87 0.0008
992 COMPLETED SUICIDE 64 0.0008
993 PRODUCT STORAGE ERROR 61 0.0007
994 DRUG DEPENDENCE 90 0.0006